Hepatera Ltd.

Industry · 4 registered clinical trials.

Status	Trial	Phase	Started
Completed	Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chro Chronic Viral Hepatitis B With Delta-agent	Phase 2	2016-04-01
Completed	A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B f Chronic Hepatitis D Infection With Hepatitis B	Phase 2	2016-02-16
Completed	Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection Chronic Hepatitis D Infection	Phase 1 / Phase 2	2014-02-13
Completed	Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B Chronic Hepatitis B	Phase 1 / Phase 2	2012-11-14